Kiwi Wealth Investments Limited Partnership’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-85,120
Closed -$7.65M 248
2021
Q1
$7.65M Buy
+85,120
New +$7.99M 0.44% 62
2020
Q4
Sell
-32,348
Closed -$3.33M 261
2020
Q3
$3.33M Buy
32,348
+2,300
+8% +$240K 0.23% 125
2020
Q2
$3.04M Sell
30,048
-5,808
-16% -$520K 0.25% 106
2020
Q1
$2.41M Buy
+35,856
New +$2.23M 0.24% 111
2019
Q3
Sell
-68,152
Closed -$2.55M 195
2019
Q2
$2.55M Buy
+68,152
New +$2.14M 0.22% 120

Other funds holding DXCM

Kiwi Wealth Investments Limited Partnership's DXCM Position: Q2 2021 in Review

Kiwi Wealth Investments Limited Partnership sold out of DexCom (DXCM) in Q2 2021, closing a stake of 85,120 shares — an estimated $7.65M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in DXCM in Q2 2019 and held it in 5 quarters. The position peaked at $7.65M in Q1 2021. 727 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

  • Kiwi Wealth Investments Limited Partnership reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 85,120 DexCom shares in Q2 2021, an estimated $7.65M.
  • Kiwi Wealth Investments Limited Partnership first reported a position in DexCom in Q2 2019 and held it in 5 quarters.
  • Kiwi Wealth Investments Limited Partnership's DexCom position peaked at $7.65M in Q1 2021.
  • 727 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q2 2021, filed 17 Aug 2021.